Published in Arch Intern Med on February 23, 1981
Reactions to acetylsalicylic acid. Can Med Assoc J (1982) 1.02
Paracetamol and phenacetin. Drugs (1986) 0.99
Prostaglandin: release from the rat phrenic nerve--diaphragm preparation. Science (1965) 2.08
Efflux of prostaglandin from adrenal glands stimulated with acetylcholine. Nature (1966) 2.07
Spontaneous and evoked release of prostaglandins from cerebral cortex of anesthetized cats. Am J Physiol (1966) 1.93
Release of prostaglandin from rat epididymal fat pad on nervous and hormonal stimulation. J Biol Chem (1968) 1.93
Thin-layer chromatography of 1-dimethylaminonaphthalene-5-sulphonyl derivatives of amino acids present in superfusates of cat cerebral cortex. Biochem J (1967) 1.90
Biological significance of the prostaglandins. Recent Prog Horm Res (1970) 1.81
The vascular protective effects of estrogen. FASEB J (1996) 1.71
Human alveolar macrophages: effects of endotoxin in vitro. Infect Immun (1980) 1.55
Spontaneous and evoked release of prostaglandins from frog spinal cord. Am J Physiol (1966) 1.43
Vascular activity of polycations and basic amino acids: L-arginine does not specifically elicit endothelium-dependent relaxation. Biochem Biophys Res Commun (1989) 1.31
Sex and age differences in human platelet aggregation. Nature (1975) 1.29
The effect of prostaglandins E1 and E2 on the human erythrocyte as monitored by spin labels. Biochem Biophys Res Commun (1974) 1.27
Vascular responses to arachidonic acid in the perfused canine lung. Circ Res (1976) 1.27
Endothelium dependent vascular relaxation by arginine containing polypeptides. Biochem Biophys Res Commun (1986) 1.23
Modification, by aspirin and indomethacin, of the haemodynamic and prostaglandin releasing effects of E. coli endotoxin in the dog. Br J Pharmacol (1977) 1.23
Prostaglandin stimulation of rat corticosteroidogenesis. Science (1969) 1.22
Prostaglandin inhibition of gastric secretion. J Physiol (1968) 1.19
Inhibition of intestinal tone and prostaglandin synthesis by 5,8,11,14 tetraynoic acid. Br J Pharmacol (1972) 1.16
Cardiovascular responses to PGI2 (prostacyclin) in the dog. Circ Res (1978) 1.12
Effect of prostaglandin synthesis on renal function and renin in the dog. Nature (1976) 1.12
Prostaglandins in reproductive physiology. Am J Obstet Gynecol (1970) 1.10
Effects of arachidonic acid on systemic arterial pressure, myocardial contractility and platelets in the dog. Proc Soc Exp Biol Med (1974) 1.03
Relationship of TXB2 and 6-keto PGF1 alpha to the hemodynamic changes during baboon endotoxic shock. Adv Prostaglandin Thromboxane Res (1980) 1.03
Role of rostaglandins in reproduction. Physiol Rev (1975) 1.01
Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats. Br J Pharmacol (1993) 0.98
Inhibition of intestinal tone, motility and prostaglandin biosynthesis by 5,8,11,14-eicosatetraynoic acid (TYA). Prostaglandins (1974) 0.98
Lidocaine or indomethacin improves survival in baboon endotoxin shock. J Surg Res (1978) 0.98
Estradiol protects against experimental cardiac transplant atherosclerosis. Transplant Proc (1987) 0.97
Prostaglandin stimulation of in vitro progesterone synthesis. J Clin Endocrinol Metab (1970) 0.96
Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg (1994) 0.96
A comparison of the effects of ACTH, cyclic AMP, Dibutyryl cyclic AMP, and PGE2 on corticosteroidogenesis in vitro. Endocrinology (1972) 0.96
Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol (1993) 0.93
Prostaglandins and the hemodynamic course of endotoxin shock. J Surg Res (1976) 0.92
In vitro effect of oestradiol on thymidine uptake in pulmonary vascular smooth muscle cell: role of the endothelium. Br J Pharmacol (1992) 0.92
Peritoneal fluid thromboxane B2 and 6-keto-prostaglandin F1 alpha in endometriosis. Am J Obstet Gynecol (1981) 0.91
Urine i-TXB2 in renal allograft rejection. Lancet (1981) 0.91
Thromboxane, prostacyclin, and hemodynamic events in primate endotoxin shock. Adv Shock Res (1981) 0.91
Biological aspects of prostaglandins. Arch Intern Med (1974) 0.91
Biological activity of synthetic prostaglandins. Nature (1969) 0.91
Renal actions of prostacyclin. Nature (1978) 0.91
Effect of cyclooxygenase inhibition on the pulmonary vasodilator response to furosemide. J Pharmacol Exp Ther (1988) 0.91
Cardiovascular and pulmonary effects of thromboxane B2 in the dog. Circ Res (1979) 0.90
The role of prostaglandins in endotoxemia: comparisons in response in the nonpregnant, maternal, and fetal models. I. Prostaglandins and the pulmonary effect of experimental endotoxemia. Am J Obstet Gynecol (1980) 0.90
Prostaglandin uptake and metabolism by the perfused rat liver. Br J Pharmacol (1970) 0.90
L-arginine reverses the adverse pregnancy changes induced by nitric oxide synthase inhibition in the rat. Am J Obstet Gynecol (1996) 0.90
Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction. J Pharmacol Exp Ther (1978) 0.89
Prostaglandins in shock: to give or to block? Adv Shock Res (1980) 0.89
NG-monomethyl L-arginine is a non-specific inhibitor of vascular relaxation. Eur J Pharmacol (1989) 0.89
Vasodilatory properties of mono-L-arginine-containing compounds. Biochem Biophys Res Commun (1988) 0.89
Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581. J Pharmacol Exp Ther (1982) 0.89
E. coli endotoxin shock in the dog; treatment with lidocaine or indomethacin. Br J Pharmacol (1978) 0.89
Gonadal hormones and pathogenesis of occlusive arterial thrombosis. Am J Physiol (1978) 0.89
Leukotrienes C4 and D4 induce prostaglandin and thromboxane release from rat peritoneal macrophages. Br J Pharmacol (1981) 0.89
Superoxide production in the isolated rabbit aorta and the effect of alloxan, indomethacin and nitrovasodilators. J Pharmacol Exp Ther (1991) 0.88
Cellular mechanisms of prostaglandin action. Annu Rev Physiol (1979) 0.88
The antithrombotic nature of vascular prosthetic pseudointima. Surgery (1982) 0.88
Estradiol increases cyclic adenosine monophosphate in rat pulmonary vascular smooth muscle cells by a nongenomic mechanism. J Pharmacol Exp Ther (1996) 0.88
The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs. Circ Shock (1980) 0.87
Effects of ganglionic and beta-adrenergic blockade on cardiovascular responses to the bisenoic prostaglandins and their precursor arachidonic acid. Proc Soc Exp Biol Med (1975) 0.87
Role of the endothelium and arginine peptides on the vaso-motor response of porcine internal mammary artery. Life Sci (1989) 0.87
Effect of testosterone, sex and age on experimentally induced arterial thrombosis. Nature (1976) 0.86
Mechanism of cyclosporin potentiation of vasoconstriction of the isolated rat mesenteric arterial bed: role of extracellular calcium. J Pharmacol Exp Ther (1990) 0.86
Ibuprofen modifies the inflammatory response of the murine lung to Pseudomonas aeruginosa. Eur J Respir Dis (1985) 0.86
Peptidyl arginine deiminase and endothelium dependent relaxation. Eur J Pharmacol (1988) 0.86
Androgen-mediated sensitivity in platelet aggregation. Am J Physiol (1977) 0.86
Antagonism of the pulmonary vasoconstrictor response to prostaglandin F2alpha by N-dimethylamino substitution of prostaglandin F2alpha. J Pharmacol Exp Ther (1978) 0.86
Cardiovascular and platelet responses in the dog to the monoenoic prostaglandin precursor dihomo-gamma-linolenic acid. Proc Soc Exp Biol Med (1975) 0.86
Prostaglandin E2: effects on aggregation, shape change and cyclic AMP of rat platelets. Prostaglandins (1972) 0.86
Prostaglandins: localization in subcellular particles of rat cerebral cortex. Science (1967) 0.85
Estradiol potentiates the vasopressor response of the isolated perfused rat lung to the thromboxane mimic U-46619. J Pharmacol Exp Ther (1992) 0.85
Role of the vascular endothelium in the contractile response to prostacyclin in the isolated rat aorta. J Pharmacol Exp Ther (1986) 0.85
Coronary artery ultrastructural changes in cardiac transplant atherosclerosis in the rabbit. Transplantation (1991) 0.84
Separation, identification, and estimation of prostaglandins. Methods Biochem Anal (1969) 0.84
Androgen-mediated sex differences of cardiovascular responses in rats. Am J Physiol (1978) 0.84
Vascular reactivity in endotoxin shock: effect of lidocaine or indomethacin pretreatment. Adv Shock Res (1982) 0.84
Interaction of non-arginine compounds with the endothelium-derived relaxing factor inhibitor, NG-monomethyl L-arginine. J Pharmacol Exp Ther (1992) 0.84
Effect of cyclosporine A treatment on vascular reactivity of the rat thoracic aorta. Transplant Proc (1988) 0.83
17-Beta estradiol regulation of myocardial glutathione and its role in protection against myocardial stunning in dogs. J Cardiovasc Pharmacol (1998) 0.83
Regulation of the arachidonic acid cascade. Biol Reprod (1977) 0.83
Endothelium-dependent gender differences in the response of the rat pulmonary artery to the thromboxane mimic (U46619). J Pharmacol Exp Ther (1986) 0.83
Systemic vascular effects of cyclosporin A treatment in normotensive rats. J Pharmacol Exp Ther (1991) 0.83
Gender differences in prostaglandin receptors of rat aorta. Br J Pharmacol (1981) 0.83
Vasoconstrictor response to arachidonic acid in the isolated hind limb of the dog. Br J Pharmacol (1977) 0.83
Non-genomic effects of estrogen and the vessel wall. Biochem Pharmacol (1996) 0.83
Effects of PGD2 on canine renal function. Nature (1977) 0.83
In vivo and in vitro effects of endotoxin on prostaglandin release from rat lung. Br J Pharmacol (1981) 0.83
Human peritoneal eosinophils and formation of arachidonate cyclooxygenase products. Scand J Immunol (1986) 0.82
Effect of gender and sex steroids on the contractile response of canine coronary and renal blood vessels. J Cardiovasc Pharmacol (1996) 0.82
Attenuation of vascular relaxation and cyclic GMP responses by cyclosporin A. J Pharmacol Exp Ther (1990) 0.82
Increase in urinary thromboxane B2 in rats caused by cyclosporine. Transplantation (1985) 0.82
Carnitine-dependent oxidation of prostaglandins. J Biol Chem (1972) 0.82
Endothelial potentiation of relaxation response to beta adrenoceptor blocking agents. J Pharmacol Exp Ther (1986) 0.82
Effect of testosterone treatment on vasoconstrictor response of left anterior descending coronary artery in male and female pigs. J Cardiovasc Pharmacol (1995) 0.82
Thromboxane inhibition in gram-negative sepsis fails to improve survival. Adv Prostaglandin Thromboxane Leukot Res (1983) 0.82
Effect of verapamil on the pulmonary vasoconstrictor action of prostaglandin F2 alpha and a synthetic PGH2 analogue. Br J Pharmacol (1981) 0.82
Vascular relaxation mediated by hydroxylamines and oximes: their conversion to nitrites and mechanism of endothelium dependent vascular relaxation. Biochem Biophys Res Commun (1989) 0.82
Role of calcium in U 46619 and PGF2 alpha pulmonary vasoconstriction in rat lungs. Am J Physiol (1989) 0.82
Effects of estrogen on cardiovascular responses of premenopausal monkeys. J Pharmacol Exp Ther (1994) 0.81
Indomethacin treatment following baboon endotoxin shock improves survival. Adv Shock Res (1980) 0.81
Brief ischemia-reperfusion induces stunning of endothelium in canine coronary artery. Circulation (1992) 0.81